Tekfen Ventures

Tekfen Ventures is an early-stage venture capital firm based in New York City, established in 2016 as the corporate venture arm of Tekfen Holding, a publicly traded Turkish industrial conglomerate founded in 1956 with more than 18,000 employees across 40 subsidiaries operating in construction, agriculture, manufacturing and real estate. Investing out of a roughly $65M fund with a financial-return focus, Tekfen Ventures backs visionary founders pursuing bold transformations in the legacy industries that build, feed and supply the world. It invests across the technology spectrum, software, hardware and life sciences, typically writing first checks of about $1M to $4M at the Series A and B stages, generally as a co-investor, and skews toward deeptech and research-based companies tied to the digitization and decarbonization of agriculture, construction, manufacturing and real estate, as well as advanced materials, energy efficiency, renewable energy, IoT, robotics and cybersecurity. Beyond capital, the firm leverages Tekfen Holding's industrial leadership, global reach and operating expertise to act as a strategic partner, and it has reviewed deals as far afield as the Philippines, Australia, India and China. Its portfolio of roughly 28 investments includes two unicorns, industrial cybersecurity company Claroty, valued at about $2.5 billion in 2024, and agricultural biotech Pivot Bio, alongside Tropic Biosciences and enterprise analytics platform Soft Machine. Its most recent tracked investment was in Tropic in August 2025. Longtime leaders Managing Director Kris Kemeny and founder-president Sinan Uzan departed the firm in January 2026. By pairing capital with a major industrial parent, Tekfen Ventures backs deeptech transforming legacy industries.